To further deepen regulatory reform, support innovation in cosmetic ingredients, and optimize the requirements for new ingredient registration and notification dossiers, the National Medical Products Administration (NMPA) has drafted the “Provisions on Management of Cosmetic New Ingredient Registration and Notification Dossiers (Revised Draft for Comments)” (Attachment 1). This draft was developed in accordance with the Cosmetic Supervision and Administration Regulation (CSAR), the Administrative Measures on Cosmetic Registration and Notification, and other relevant regulations, while considering the current state of industry development. We are now formally soliciting public feedback.
The public comment period is from December 26, 2025, to January 25, 2026. Please provide your comments and suggestions by completing the Feedback Form (Attachment 2) and sending it to the following email address: hzpjgyc@nmpa.gov.cn. Please indicate “Feedback on Provisions on Management of Cosmetic New Ingredient Registration and Notification Dossiers” in the email subject line.
Attachments:
- Provisions on Management of Cosmetic New Ingredient Registration and Notification Dossiers (Revised Draft for Comments)
- Feedback Form for Comments and Suggestions
General Affairs Department of the NMPA December 24, 2025
